Drug shortages affect public pharmacies in Brusque, Guabiruba and Botuverá

In recent months, city halls and commercial pharmacies have registered a lack of medicines in Brusque, Guabiruba and Botuverá. The situation is not only felt in the region, but throughout the country.

The shortage is of antibiotics and other medicines used in the treatment of respiratory syndromes, such as syrups and anti-flu. In Brusque, the city hall reports a lack of basic medicines, such as amoxicillin, ibuprofen and loratadine syrup, for example.

According to the director of Pharmaceutical Care, Patricia Bernardi Sassi, the team works to replace the medicines as soon as possible. However, she points out that the problem is linked to the lack of inputs for production that affects the country. “We work intensively, making contact with companies, but unfortunately the situation is global”, she points out.

Part of the medicines purchased by the city hall are the result of an agreement with the Intermunicipal Health Consortium of the Middle Valley of Itajaí (Cisamvi). The consortium buys medicines and other supplies for all municipalities in the region, such as Guabiruba and Botuverá, in addition to two other cities in the Foz do Itajaí region.

The executive director of Cisamvi, Vanessa Fernanda Schmitt, reports difficulties and says that all 14 consortia in the state are in the same situation.

“It’s not just today, it’s a state and country situation. We have monthly meetings and this topic is on the agenda. We are working closely with suppliers to understand what is happening and asking for clarification. We even open administrative proceedings against the company when there is no delivery and no justification,” he says.

Vanessa details that, in total, 277 items of medication are purchased by the consortium and a large part is overdue. Other missing medications are azithromycin and dipyrone.

Check out medicines that are out of stock in Brusque:

Below, the list shows the lack of medicines in the public network updated this Monday, 18.

basic medicines
– Amoxicillin 50mg/ml oral suspension
– Amoxicillin + Clavulanate 50mg + 12.5mg/ml oral suspension
– Amoxicillin + Clavulanate 500mg + 125mg tablets
– Oral Rehydration Salts – 6000
– Ambroxol 6mg/ml adult
– Paracetamol 200mg/ml drops
– Ibuprofen 600mg tablets
– Ipratropium drops 20ml
– Mineral oil 100ml
– Cephalexin suspension
– Loratadine syrup
– Ferrous Sulfate 125mg/ml drops

controlled drugs
– Tramadol 50mg
– Risperidone 1mg tablet

Lack of raw material

A survey by the National Confederation of Municipalities (CNM) carried out with 2,469 municipalities shows a scenario of drug shortages in Brazilian cities. The survey found that more than 80% of managers reported suffering from a lack of medicines to meet the needs of the population.

Vanessa points out that, to Cisamvi, all suppliers claim the lack of inputs, mainly due to the importation of raw materials. In the country, about 95% of medicines in the country depend on imported inputs, mainly from India and China.

In the last two years, the Covid-19 pandemic, with the recent lockdown in China, and the War in Ukraine have impacted the sector, according to the director. Added to the flu and dengue outbreaks recorded this year, many medicines were in short supply.

“Industry is experiencing a lack of these assets. As much as we do not have an official suspension by Anvisa, companies do not want to discontinue the production of medicines. They want to regularize production so that, when they receive the raw material, they can deliver this demand. In this case, Cisamvi needs to deliver what is in the contract”, Vanessa continues.

Currently, deliveries are being negotiated with the companies. “Now, our job is to accompany these suppliers and put into practice what the public notice brings. Every day is a day. We will always follow. All medicines are being effectively traded. From the ups and downs we went through, I have no doubt that we will go through this shortage”, he adds.

According to the Federal Pharmacy Council (CFF), the shortage of essential medicines is also caused by the discontinuation of the production of some drugs by the industry to prioritize medicines with greater demand generated by the Covid-19 pandemic; dissemination of epidemics, notably of respiratory syndromes and viral diseases; and the need to replace drugs that are in short supply, which generates a cascading effect, making it difficult to access drugs that replace those with the most critical supply.


In Guabiruba, the pharmacist responsible for the technique of the Health Department, Heloá Klabunde Maestri, comments that the lack of medicines affects the service in the network.

“It’s real, this shortage is not just in the public network, but in the private network as well. Patients end up having to return to the doctor, as they cannot find the medicine either here at the pharmacy or to buy it. They go back to the doctor to give them another option,” she reports.

Heloá points out that, as the problem has been going on for more than a month, doctors are already more prepared when it comes to prescribing a drug. “It is a national reality. That is, doctors end up giving patients other options so that they can buy. For now we’re fixing it, but I don’t know how long the system will last. Companies didn’t give us forecast,” he comments.


In Botuverá, the Municipal Health Secretary, Márcia Cansian, says that the municipality is also part of the Santa Catarina Interfederative Consortium (Cincatarina).

However, even for being a small city, which facilitates the direct purchase by necessity, the lack of raw material affects the acquisition. “Even if some regions have medicines for a certain period, then they won’t have them anymore”, he emphasizes.

A highlight, cited by the secretary, is the difficulty of buying antibiotics. In this case, to solve the problem, the network ends up relocating with other drugs that have the same effect.

“What will end up happening, if this is not resolved as well, is an increase in the number of hospitalizations due to lack of outpatient treatment. In other words, the lack of these medicines causes the worsening of the condition”, he evaluates.

Saline solution

In addition to medications, Márcia cites the lack of saline solution, widely used in the treatment of patients with dengue. “We took precautions, we made an important purchase. We are making a price registration act with the state, which buys for all municipalities,” she says.

However, the concern of health professionals is with the end of winter, when the warmer seasons provide the proliferation of the Aedes aegypti mosquito.

“We also have to do the work ahead of time because we are in winter and with the dengue situation. All the prevention work and guidance to the population has not diminished”, he concludes.